{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:54:59Z","timestamp":1768715699552,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.rmed.2021.106482","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T09:48:43Z","timestamp":1622108923000},"page":"106482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis"],"prefix":"10.1016","volume":"185","author":[{"given":"Rapha\u00ebl","family":"Hurtubise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Gyger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell J.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-5729","authenticated-orcid":false,"given":"Sabrina","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.rmed.2021.106482_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2021.106482_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2021.106482_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2008.091710","article-title":"Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study","volume":"68","author":"Vonk","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2021.106482_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"10","key":"10.1016\/j.rmed.2021.106482_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2021.106482_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.rmed.2021.106482_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring","volume":"179","author":"Savarino","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2021.106482_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","article-title":"Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study","volume":"46","author":"Richardson","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.rmed.2021.106482_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/resp.13309","article-title":"Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease","volume":"23","author":"Winstone","year":"2018","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.rmed.2021.106482_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3899\/jrheum.120705","article-title":"Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis","volume":"40","author":"Zhang","year":"2013","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.rmed.2021.106482_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.rmed.2021.106482_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000156958","article-title":"Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis","volume":"77","author":"de Souza","year":"2009","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.rmed.2021.106482_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000592","article-title":"Management of systemic sclerosis-associated interstitial lung disease","volume":"31","author":"Roofeh","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"10.1016\/j.rmed.2021.106482_bib14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/acr.22451","article-title":"American College of Rheumatology\/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group","volume":"67","author":"Alhajeri","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.rmed.2021.106482_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semarthrit.2017.03.019","article-title":"Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis","volume":"47","author":"Hax","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"issue":"13","key":"10.1016\/j.rmed.2021.106482_bib16","first-page":"1","article-title":"An R package for inverse probability weighting","volume":"43","author":"Van der Wal","year":"2011","journal-title":"J. Stat. Software"},{"issue":"28","key":"10.1016\/j.rmed.2021.106482_bib17","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"issue":"5","key":"10.1016\/j.rmed.2021.106482_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hernan","year":"2000","journal-title":"Epidemiology"},{"issue":"12","key":"10.1016\/j.rmed.2021.106482_bib19","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/pds.4325","article-title":"Comparison of the ability of double-robust estimators to correct bias in propensity score matching analysis. A Monte Carlo simulation study","volume":"26","author":"Nguyen","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.rmed.2021.106482_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2202\/1557-4679.1106","article-title":"Missing confounding data in marginal structural models: a comparison of inverse probability weighting and multiple imputation","volume":"4","author":"Moodie","year":"2008","journal-title":"Int. J. Biostat."},{"issue":"3","key":"10.1016\/j.rmed.2021.106482_bib21","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.rmed.2021.106482_bib22","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"issue":"3","key":"10.1016\/j.rmed.2021.106482_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2217\/cer-2017-0071","article-title":"Handling missing data in propensity score estimation in comparative effectiveness evaluations: a systematic review","volume":"7","author":"Malla","year":"2018","journal-title":"J. Comp. Eff. Res."},{"issue":"12","key":"10.1016\/j.rmed.2021.106482_bib24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.201101-0138OC","article-title":"Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis","volume":"184","author":"Lee","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2021.106482_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00376-2018","article-title":"The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies","volume":"51","author":"Tran","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2021.106482_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","article-title":"Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2021.106482_bib27","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2021.106482_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","article-title":"Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis","volume":"4","author":"Kreuter","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2021.106482_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000468546","article-title":"Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received pirfenidone","volume":"93","author":"Kreuter","year":"2017","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.rmed.2021.106482_bib30","article-title":"Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients","volume":"30","author":"Stern","year":"2018","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"9","key":"10.1016\/j.rmed.2021.106482_bib31","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.1987.00370090075014","article-title":"Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities","volume":"147","author":"Johnson","year":"1987","journal-title":"Arch. Intern. Med."},{"issue":"11","key":"10.1016\/j.rmed.2021.106482_bib32","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment algorithms for systemic sclerosis according to experts","volume":"70","author":"Fernandez-Codina","year":"2018","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.rmed.2021.106482_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"12","key":"10.1016\/j.rmed.2021.106482_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.rmed.2021.106482_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.rmed.2021.106482_bib36","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.jid.2017.06.019","article-title":"Early-life antibiotic exposure causes intestinal dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis","volume":"137","author":"Mehta","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.rmed.2021.106482_bib37","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.rmed.2021.106482_bib38","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.rmed.2021.106482_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1078\/0344-0338-00305","article-title":"Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia","volume":"198","author":"de Carvalho","year":"2002","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2021.106482_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"2 Suppl 1","key":"10.1016\/j.rmed.2021.106482_bib41","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:22:18Z","timestamp":1760617338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121001888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"alternative-id":["S0954611121001888"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106482","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106482"}}